Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Bruce I Sachs. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at Bruce I Sachs har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:VRTX / Vertex Pharmaceuticals Incorporated Director 45 000
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Bruce I Sachs. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av Bruce I Sachs som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2025-08-07 2025-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 3 366 45 000 8,08 389,84 1 312 201 17 542 800
2025-08-07 2025-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 1 634 41 634 4,08 389,36 636 214 16 210 614
2024-08-02 2024-08-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 295 40 000 −11,69 508,00 −2 689 860 20 320 000
2024-08-02 2024-08-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5 295 45 295 13,24 125,71 665 634 5 694 034
2024-05-24 2024-05-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −7 073 40 000 −15,03 448,00 −3 168 704 17 920 000
2024-05-24 2024-05-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7 073 47 073 17,68 93,51 661 396 4 401 796
2023-11-08 2023-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −11 250 40 000 −21,95 385,00 −4 331 250 15 400 000
2023-11-08 2023-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 11 250 51 250 28,12 127,54 1 434 825 6 536 425
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 842 40 000 −8,76 357,29 −1 372 708 14 291 600
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 711 43 842 −11,53 356,75 −2 037 399 15 640 634
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 697 49 553 −3,31 355,54 −603 351 17 618 074
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 11 250 51 250 28,12 127,54 1 434 825 6 536 425
2023-04-14 2023-04-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift −1 210 40 000 −2,94
2023-04-14 2023-04-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −8 026 41 210 −16,30 327,48 −2 628 354 13 495 451
2023-04-14 2023-04-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −10 357 49 236 −17,38 326,46 −3 381 146 16 073 585
2023-04-14 2023-04-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 917 59 593 −4,67 325,65 −949 921 19 406 460
2023-04-14 2023-04-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 21 300 62 510 51,69 72,14 1 536 582 4 509 471
2023-02-02 2023-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 200 41 210 −2,83 325,01 −390 012 13 393 662
2023-02-02 2023-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 200 42 410 2,91 72,14 86 568 3 059 457
2022-05-03 2022-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 4 462 4 462
2022-04-18 2022-04-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 151 13 824 1,11 289,41 43 750 4 000 661
2022-01-19 2022-01-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 190 13 672 1,41 230,58 43 750 3 152 568
2021-10-18 2021-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 240 13 483 1,81 182,07 43 750 2 454 777
2021-08-04 2021-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 15 000 41 210 57,23 197,91 2 968 650 8 155 871
2021-07-16 2021-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 221 13 242 1,70 198,00 43 750 2 621 977
2021-05-04 2021-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 6 067 6 067
2021-04-16 2021-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 199 13 021 1,55 220,17 43 750 2 866 910
2021-01-19 2021-01-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 194 12 823 1,53 225,99 43 750 2 897 787
2020-11-12 2020-11-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 3 905 26 210 17,51 218,79 854 375 5 734 486
2020-11-12 2020-11-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 4 270 22 305 23,68 217,49 928 682 4 851 114
2020-11-12 2020-11-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 6 825 18 035 60,88 216,47 1 477 408 3 904 036
2020-10-19 2020-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 196 12 629 1,58 222,81 43 750 2 813 877
2020-07-17 2020-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 155 12 433 1,26 292,77 45 453 3 639 917
2020-06-03 2020-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 4 527 4 527
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −22 500 0 −100,00
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −22 500 0 −100,00
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 960 11 210 −20,89 272,46 −806 482 3 054 277
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −6 232 14 170 −30,55 271,63 −1 692 798 3 848 997
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 889 20 402 −22,40 270,49 −1 592 916 5 518 537
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −15 751 26 291 −37,46 269,53 −4 245 367 7 086 213
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −11 568 42 042 −21,58 268,65 −3 107 743 11 294 583
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 600 53 610 −4,63 267,50 −695 500 14 340 675
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 22 500 56 210 66,75 81,54 1 834 650 4 583 363
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 22 500 33 710 200,71 59,55 1 339 875 2 007 430
2020-04-17 2020-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 179 12 277 1,48 258,56 46 250 3 174 453
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −20 000 0 −100,00
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −100 11 210 −0,88 235,40 −23 540 2 638 834
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −900 11 310 −7,37 234,15 −210 735 2 648 236
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 800 12 210 −12,85 233,13 −419 634 2 846 517
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 200 14 010 −7,89 232,04 −278 448 3 250 880
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 200 15 210 −7,31 230,87 −277 044 3 511 533
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −500 16 410 −2,96 229,90 −114 950 3 772 659
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −600 16 910 −3,43 228,33 −136 998 3 861 060
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −300 17 510 −1,68 227,66 −68 298 3 986 327
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 644 17 810 −24,06 227,01 −1 281 244 4 043 048
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 198 23 454 −15,18 226,32 −950 091 5 308 109
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 858 27 652 −6,30 224,98 −418 013 6 221 147
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 700 29 510 −5,45 224,02 −380 834 6 610 830
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 20 000 31 210 178,41 53,85 1 077 000 1 680 658
2020-01-17 2020-01-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 200 12 099 1,68 231,55 46 250 2 801 421
2019-10-17 2019-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 264 11 899 2,26 175,50 46 250 2 088 242
2019-07-17 2019-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 257 11 635 2,26 176,39 45 371 2 052 348
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 1 801 11 378 18,81
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 6 659 6 659
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer −1 801 11 210 −13,84
2019-04-17 2019-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 247 9 577 2,65 182,28 45 000 1 745 707
2019-01-16 2019-01-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 243 9 330 2,68 184,90 45 000 1 725 152
2019-01-02 2018-12-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift −10 000 13 011 −43,46
2018-12-07 2018-12-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −10 000 0 −100,00
2018-12-07 2018-12-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10 000 23 011 76,86 34,24 342 400 787 897
2018-10-17 2018-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 251 9 087 2,84 179,29 45 000 1 629 175
2018-07-18 2018-07-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 249 8 836 2,90 180,97 45 000 1 599 019
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 2 188 8 587 34,19
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 3 229 3 229
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer −2 188 13 011 −14,40
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 1 801 15 199 13,44
2018-04-18 2018-04-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 280 6 399 4,57 160,89 45 000 1 029 561
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 262 6 119 4,47 157,50 41 250 963 816
2018-01-17 2017-12-20 5 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift −10 000 13 398 −42,74
2017-10-18 2017-10-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 265 5 858 4,75 155,44 41 250 910 500
2017-07-19 2017-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 317 5 592 6,01 130,15 41 250 727 823
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 2 941 5 275 125,99
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 5 295 5 295
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer −2 941 23 398 −11,17
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 2 188 26 339 9,06
2017-04-19 2017-04-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 360 2 334 18,24 114,58 41 250 267 458
2017-01-19 2017-01-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 508 1 974 34,67 81,16 41 250 160 229
2016-10-19 2016-10-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 516 1 466 54,25 80,01 41 250 117 293
2016-07-19 2016-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 461 950 94,25 89,45 41 250 85 015
2016-06-03 2016-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 7 073 7 073
2016-06-03 2016-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 2 941 24 151 13,87 0,01 29 242
2016-04-19 2016-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 489 489 87,60 42 860 42 860
2015-08-05 2015-08-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −10 000 10 000 −50,00
2015-08-05 2015-08-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −10 000 21 210 −32,04 140,13 −1 401 300 2 972 157
2015-08-05 2015-08-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10 000 31 210 47,15 34,24 342 400 1 068 630
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 22 500 22 500
2015-03-24 2015-03-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −10 000 0 −100,00
2015-03-24 2015-03-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 375 21 210 −6,09 136,14 −187 192 2 887 529
2015-03-24 2015-03-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −8 625 22 585 −27,64 135,42 −1 167 998 3 058 461
2015-03-24 2015-03-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10 000 31 210 47,15 29,89 298 900 932 867
2015-03-20 2015-03-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −10 000 10 000 −50,00
2015-03-20 2015-03-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −10 000 21 210 −32,04 130,13 −1 301 300 2 760 057
2015-03-20 2015-03-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10 000 31 210 47,15 29,89 298 900 932 867
2015-01-22 2015-01-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −139 0 −100,00
2015-01-22 2015-01-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −139 21 210 −0,65 125,00 −17 375 2 651 250
2015-01-22 2015-01-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 139 21 349 0,66 28,40 3 948 606 312
2015-01-13 2015-01-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −9 861 139 −98,61
2015-01-13 2015-01-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −9 861 21 210 −31,74 125,04 −1 233 019 2 652 098
2015-01-13 2015-01-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 9 861 31 071 46,49 28,40 280 052 882 416
2014-12-01 2014-11-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −10 000 10 000 −50,00
2014-12-01 2014-11-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −10 000 21 210 −32,04 120,03 −1 200 300 2 545 836
2014-12-01 2014-11-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10 000 31 210 47,15 28,40 284 000 886 364
2014-11-07 2014-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −9 900 0 −100,00
2014-11-07 2014-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −9 900 21 210 −31,82 115,21 −1 140 579 2 443 604
2014-11-07 2014-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 9 900 31 110 46,68 29,84 295 416 928 322
2014-11-05 2014-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −100 9 900 −1,00
2014-11-05 2014-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −100 21 210 −0,47 111,86 −11 186 2 372 551
2014-11-05 2014-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 100 21 310 0,47 29,84 2 984 635 890
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −10 000 10 000 −50,00
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −100 21 210 −0,47 115,45 −11 545 2 448 694
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 400 21 310 −17,11 114,23 −502 612 2 434 241
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 200 25 710 −11,07 113,47 −363 104 2 917 314
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 300 28 910 −7,37 112,47 −258 681 3 251 508
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10 000 31 210 47,15 29,84 298 400 931 306
2014-11-05 2014-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −20 000 0 −100,00
2014-11-05 2014-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 684 21 210 −11,23 112,80 −302 755 2 392 488
2014-11-05 2014-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −17 316 23 894 −42,02 112,03 −1 939 911 2 676 845
2014-11-05 2014-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 20 000 41 210 94,30 34,32 686 400 1 414 327
2014-06-03 2014-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 22 500 22 500
2014-03-25 2014-03-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −500 21 210 −2,30 76,57 −38 285 1 624 050
2014-03-25 2014-03-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 000 21 710 −12,14 75,25 −225 750 1 633 678
2014-03-25 2014-03-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 750 24 710 −10,01 74,47 −204 792 1 840 154
2014-03-25 2014-03-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 450 27 460 −8,19 73,53 −180 148 2 019 134
2014-02-24 2014-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 200 29 910 −9,66 84,13 −269 216 2 516 328
2014-02-24 2014-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 800 33 110 −10,30 83,65 −317 870 2 769 652
2014-02-24 2014-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 300 36 910 −3,40 82,51 −107 263 3 045 444
2014-01-23 2014-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −400 38 210 −1,04 86,91 −34 764 3 320 831
2014-01-23 2014-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 500 38 610 −3,74 85,87 −128 805 3 315 441
2014-01-23 2014-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −600 40 110 −1,47 84,90 −50 940 3 405 339
2014-01-23 2014-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 800 40 710 −12,47 83,89 −486 562 3 415 162
2013-12-26 2013-12-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 200 46 510 −2,52 73,45 −88 140 3 416 160
2013-12-26 2013-12-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −7 100 47 710 −12,95 72,95 −517 945 3 480 444
2013-11-21 2013-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −200 54 810 −0,36 67,15 −13 430 3 680 492
2013-11-21 2013-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 700 55 010 −3,00 66,25 −112 625 3 644 412
2013-11-21 2013-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 900 56 710 −7,95 65,35 −320 215 3 705 998
2013-11-21 2013-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −800 61 610 −1,28 64,21 −51 368 3 955 978
2013-11-21 2013-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −700 62 410 −1,11 63,10 −44 170 3 938 071
2013-10-25 2013-10-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 800 63 110 −8,42 77,17 −447 586 4 870 199
2013-10-25 2013-10-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 500 68 910 −3,50 76,80 −192 000 5 292 288
2013-09-26 2013-09-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 500 71 410 −3,38 75,23 −188 075 5 372 174
2013-09-26 2013-09-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 800 73 910 −7,28 74,86 −434 188 5 532 903
2013-09-03 2013-08-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −600 79 710 −0,75 77,97 −46 782 6 214 989
2013-09-03 2013-08-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −6 010 80 310 −6,96 77,29 −464 513 6 207 160
2013-09-03 2013-08-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 690 86 320 −1,92 76,55 −129 370 6 607 796
2013-07-26 2013-07-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −600 88 010 −0,68 87,03 −52 218 7 659 510
2013-07-26 2013-07-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 700 88 610 −2,96 85,89 −231 903 7 610 713
2013-07-26 2013-07-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 000 91 310 −5,19 85,10 −425 500 7 770 481
2013-06-24 2013-06-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 700 96 310 −2,73 76,53 −206 631 7 370 604
2013-06-24 2013-06-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 500 99 010 −4,35 75,85 −341 325 7 509 908
2013-06-24 2013-06-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 100 103 510 −1,05 74,81 −82 291 7 743 583
2013-06-04 2013-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 22 500 22 500
2013-05-23 2013-05-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 262 104 610 −3,91 80,63 −343 645 8 434 704
2013-05-23 2013-05-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 538 108 872 −1,39 79,50 −122 271 8 655 324
2013-05-23 2013-05-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 500 110 410 −2,21 78,48 −196 200 8 664 977
2013-05-16 2013-05-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale −60 000 112 910 −34,70 81,15 −4 869 000 9 162 646
2013-05-08 2013-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −7 000 172 910 −3,89 77,41 −541 870 13 384 963
2013-05-08 2013-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 300 179 910 −0,72 76,19 −99 047 13 707 343
2012-06-01 2012-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 22 500 22 500
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)